Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Petitou

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Nature|July 17, 1986
Controversial glycosaminoglycan conformationsB Casu, J Choay, D R Ferro, et al.
Journal of Medicinal Chemistry|October 28, 1997
New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agentA Badorc, M F Bordes, P de Cointet, et al.
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Journal of Medicinal Chemistry|November 12, 1993
Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effectT Bârzu, M Level, M Petitou, et al.
Organic & Biomolecular Chemistry|January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applicationsB Kuhnast, A El Hadri, R Boisgard, et al.
British Journal of Haematology|November 1, 1994
Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in miceZ X Shen, N Basara, X D Xi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 6, 2001
Experimental proof for the structure of a thrombin-inhibiting heparin moleculeM Petitou, A Imberty, P Duchaussoy, et al.
Carbohydrate Research|August 31, 1999
Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibitionP Duchaussoy, G Jaurand, P A Driguez, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 5, 2002
Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparinS K Das, J M Mallet, J Esnault, et al.
Blood|May 30, 1998
Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Nature|July 17, 1986
Controversial glycosaminoglycan conformationsB Casu, J Choay, D R Ferro, et al.
Journal of Medicinal Chemistry|October 28, 1997
New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agentA Badorc, M F Bordes, P de Cointet, et al.
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Journal of Medicinal Chemistry|November 12, 1993
Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effectT Bârzu, M Level, M Petitou, et al.
Organic & Biomolecular Chemistry|January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applicationsB Kuhnast, A El Hadri, R Boisgard, et al.
British Journal of Haematology|November 1, 1994
Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in miceZ X Shen, N Basara, X D Xi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 6, 2001
Experimental proof for the structure of a thrombin-inhibiting heparin moleculeM Petitou, A Imberty, P Duchaussoy, et al.
Carbohydrate Research|August 31, 1999
Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibitionP Duchaussoy, G Jaurand, P A Driguez, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 5, 2002
Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparinS K Das, J M Mallet, J Esnault, et al.
Blood|May 30, 1998
Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharideJ M Herbert, J P Hérault, A Bernat, et al.
Pageof 12